Visual summary
A safety signal in one drug or trial does not automatically establish a uniform class effect. Absolute risk, comparator, population, and outcome definition matter.
Text version
Glucose loss changes the environment
SGLT2 inhibition produces glycosuria and has effects beyond glucose lowering. Adverse-event categories require careful separation rather than a single infection label.
Separate common symptoms from emergencies
Genital itching or discharge suggests a different problem from fever with flank pain or rapidly progressive perineal pain/swelling. The latter requires urgent assessment for necrotizing infection. Nausea, abdominal pain, and tachypnea also require evaluation for ketoacidosis even without marked hyperglycemia.
Evaluate the actual syndrome
Do not assume bacteriuria, candidiasis, necrotizing infection, and wound healing are equivalent outcomes. Consider baseline diabetes, vascular disease, and immune risk.
Interrupt for a defined reason
Severe illness, prolonged fasting, surgery, or suspected ketoacidosis warrants reassessment and temporary interruption under the drug’s prescribing guidance. Treat uncomplicated genital infection and evaluate recurrence rather than assuming every infection requires permanent loss of an otherwise beneficial therapy.
Promote prevention
Discuss hygiene, hydration within the patient's plan, early symptom reporting, foot care, and clear illness instructions.
Avoid class-wide overstatement
A safety signal in one drug or trial does not automatically establish a uniform class effect. Absolute risk, comparator, population, and outcome definition matter.